MiMedx Group Inc. [NASDAQ: MDXG] loss -5.17% or -0.58 points to close at $10.63 with a heavy trading volume of 1067098 shares. The company report on April 22, 2021 that MiMedx to Host First Quarter 2021 Operating and Financial Results Conference Call on April 29.
MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, announced that it will report financial results for the first quarter ended March 31, 2021 after the market close on Wednesday, April 28, 2021. MiMedx management will host a webcast and conference call to review its results on Thursday, April 29, 2021, beginning at 8:30 am Eastern Time. Participating on the call will be Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer.
The conference call can be accessed using the following information:.
It opened the trading session at $11.20, the shares rose to $11.20 and dropped to $10.02, the range by which the price of stock traded the whole day. The daily chart for MDXG points out that the company has recorded 66.61% gains over the past six months. However, it is still -222.12% lower than its most recent low trading price.
If we look at the average trading volume of 554.05K shares, MDXG reached to a volume of 1067098 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about MiMedx Group Inc. [MDXG]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MDXG shares is $18.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MDXG stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for MiMedx Group Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 19, 2021.
The Average True Range (ATR) for MiMedx Group Inc. is set at 0.77, with the Price to Sales ratio for MDXG stock in the period of the last 12 months amounting to 4.52.
Trading performance analysis for MDXG stock
MiMedx Group Inc. [MDXG] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.26. With this latest performance, MDXG shares gained by 8.03% in over the last four-week period, additionally plugging by 66.61% over the last 6 months – not to mention a rise of 180.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDXG stock in for the last two-week period is set at 46.63, with the RSI for the last a single of trading hit 42.00, and the three-weeks RSI is set at 49.22 for MiMedx Group Inc. [MDXG]. The present Moving Average for the last 50 days of trading for this stock 10.43, while it was recorded at 10.76 for the last single week of trading, and 7.91 for the last 200 days.
MiMedx Group Inc. [MDXG]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and MiMedx Group Inc. [MDXG] shares currently have an operating margin of -17.87 and a Gross Margin at +82.21. MiMedx Group Inc.’s Net Margin is presently recorded at -19.85.
Return on Total Capital for MDXG is now -35.87, given the latest momentum, and Return on Invested Capital for the company is -40.85. Return on Equity for this stock declined to -78.34, with Return on Assets sitting at -26.70. When it comes to the capital structure of this company, MiMedx Group Inc. [MDXG] has a Total Debt to Total Equity ratio set at 56.70. Additionally, MDXG Total Debt to Total Capital is recorded at 36.18, with Total Debt to Total Assets ending up at 25.66.
Reflecting on the efficiency of the workforce at the company, MiMedx Group Inc. [MDXG] managed to generate an average of -$67,053 per employee. Receivables Turnover for the company is 6.38 with a Total Asset Turnover recorded at a value of 1.34.MiMedx Group Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.50 and a Current Ratio set at 2.70.
MiMedx Group Inc. [MDXG]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MDXG. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MiMedx Group Inc. go to 15.00%.
An analysis of insider ownership at MiMedx Group Inc. [MDXG]
There are presently around $431 million, or 44.40% of MDXG stock, in the hands of institutional investors. The top three institutional holders of MDXG stocks are: ESSEX WOODLANDS MANAGEMENT, INC. with ownership of 19,480,519, which is approximately New of the company’s market cap and around 2.70% of the total institutional ownership; VANGUARD GROUP INC, holding 4,059,415 shares of the stock with an approximate value of $43.15 million in MDXG stocks shares; and RTW INVESTMENTS, LP, currently with $28.7 million in MDXG stock with ownership of nearly 0% of the company’s market capitalization.
Positions in MiMedx Group Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 87 institutional holders increased their position in MiMedx Group Inc. [NASDAQ:MDXG] by around 36,259,959 shares. Additionally, 10 investors decreased positions by around 181,481 shares, while 13 investors held positions by with 4,141,483 shares. The mentioned changes placed institutional holdings at 40,582,923 shares, according to the latest SEC report filing. MDXG stock had 85 new institutional investments in for a total of 36,132,461 shares, while 3 institutional investors sold positions of 20,023 shares during the same period.